COVID start-up based in GOP donor’s luxury condo could get millions from U.S.

An obscure South Carolina company may be in line for millions of dollars in U.S. government funding to produce a coronavirus treatment after a former Republican senator with a financial stake in the business lobbied senior U.S. government officials, the Associated Press reports.

Plasma Technologies LLC, has received seed money to test a possible COVID-19-fighting blood plasma technology. But as much as $65 million more could be on the way, a windfall for the company that operates out of the founder’s luxury condo, according to internal government records and other documents obtained by the Associated Press.

The story of how a tiny business that exists only on paper has managed to snare so much top-level attention is emblematic of the Trump administration’s frenetic response to the coronavirus pandemic.

And it’s another in a series of contracts awarded despite concerns over their proposals voiced by government scientists. The others include a

Read More

COVID start-up based in GOP donor’s condo could get millions from U.S.

An obscure South Carolina company may be in line for millions of dollars in U.S. government funding to produce a coronavirus treatment after a former Republican senator with a financial stake in the business lobbied senior U.S. government officials, the Associated Press reports.



Rick Santorum wearing a suit and tie: ap-16348667977848.jpg


© Seth Wenig, AP
ap-16348667977848.jpg

Plasma Technologies LLC, has received seed money to test a possible COVID-19-fighting blood plasma technology. But as much as $65 million more could be on the way, a windfall for the company that operates out of the founder’s luxury condo, according to internal government records and other documents obtained by the Associated Press.

“No COVID-19 tests were available”: Inside the country’s first COVID-19 outbreak

UP NEXT

UP NEXT

The story of how a tiny business that exists only on paper has managed to snare so much top-level attention is emblematic of the Trump administration’s frenetic response to the coronavirus pandemic.

Loading...

Load

Read More